Transient splenial lesion of the corpus callosum after acute withdrawal of antiepileptic drug: A case report

Magnetic Resonance in Medical Sciences

Volumn 5, Issue 4, 2006, Pages 211-215

  Honda, Kazuhiro ^a   Nishimiya, Jin ^a   Sato, Hideki ^a   Munakata, Maki ^a   Kamada, Masaki ^a   Iwamura, Akihide ^a   Nemoto, Hideaki ^a   Sakamoto, Takashi ^a   Yuasa, Tatsuhiko ^a  

^a 1 7 1 Kohnodai   (Japan)

Author keywords

Carbamazepine; Corpus callosum; Diabetes insipidus; Diffusion weighted image; Splenium

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE;

ACUTE DISEASE; ARTICLE; BRAIN DISEASE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CORPUS CALLOSUM; DRUG EFFECT; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; TIME; WITHDRAWAL SYNDROME;

ACUTE DISEASE; ANTICONVULSANTS; BRAIN DISEASES; CARBAMAZEPINE; CORPUS CALLOSUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 34249677946     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.5.211     Document Type: Article

References (14)

1. Kim SS, Chang KH, Kim ST, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol 1999; 20:125-129.
2. Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry 2001; 70:459-463.
3. Tada H, Takanashi J, Barkovich AJ, et al. Clinically mild encephalitisWencephalopathy with a reversible splenial lesion. Neurology 2004; 63: 1854-1858.
4. Gurtler S, Ebner A, Tuxhorn I, Ollech I, Pohlmann-Eden B, Woermann FG. Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal. Neurology 2005; 65:1032-1036.
5. Maeda M, Shiroyama T, Tsukahara H, Shimono T, Aoki S, Takeda K. Transient splenial lesion of the corpus callosum associated with antiepileptic drugs: evaluation by diffusion-weighted MR imaging. Eur Radiol 2003; 13:1902-1906.
6. Krause KH, Rascher W, Berlit P. Plasma arginine vasopressin concentrations in epileptics under monotherapy. J Neurol 1983; 230:193-196.
7. StephensWP, Coe JY, Baylis PH. Plasma arginine vasopressin concentrations and antidiuretic action of carbamazepine. Br Med J 1978; 1:1445-1447.
8. Huang TL. Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia. Psychiatry Clin Neurosci 2005; 59:52-55.
9. Tan QR, Wang W, Wang HH, Zhang RG, Guo L, Zhang YH. Treatment of catatonic stupor with combination of modified electroconvulsive treatment and olanzapine: a case report. Clin Neuropharmacol 2006; 29:154-156.
10. Soelberg Sorensen P, Hammer M. Effects of longterm carbamazepine treatment on water metabolism and plasma vasopressin concentration. Eur J Clin Pharmacol 1984; 26:719-722.
11. Prilipko O, Delavelle J, Lazeyras F, Seeck M. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review. Epilepsia 2005; 46:1633-1636.
12. Doherty MJ, Jayadev S, Watson NF, Konchada RS, Hallam DK. Clinical implications of splenium magnetic resonance imaging signal changes. Arch Neurol 2005; 62:433-437.
13. Hagemann G, Mentzel HJ, Weisser H, Kunze A, Terborg C. Multiple reversible MR signal changes caused by Epstein-Barr virus encephalitis. AJNR Am J Neuroradiol 2006; 27:1447-1449.
14. Takanashi J, Barkovich AJ, Yamaguchi K, Kohno Y. Influenza-associated encephalitisWencephalopathy with a reversible lesion in the splenium of the corpus callosum: a case report and literature review. AJNR Am J Neuroradiol 2004; 25:798-802.